HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cold Sore Ad Claims Review Poses Test For OTC Monograph Indications

This article was originally published in The Rose Sheet

Executive Summary

Council of Better Business Bureaus forwards review of ad claims for Aubio Life Sciences' monograph cold sore treatment to US FDA and FTC, after firm rejected advice to discontinue certain claims. Initial challenge was brought by GSK, which markets an NDA cold sore product.


Related Content

Boots' Symptoms Claim For Dual Defence Not A Prevention Pitch – UK Regulator
Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review
Athlete's Foot Firm Kicks Back On NAD Finding That Brand Is A Fungal Claim
Prestige Brands Stands By Nix Lice 'Kill' Claims Despite NAD Objection
FTC Enforcement Hangs Over Memory Product Firm After Overlooking NAD Review


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts